产品封面图
文献支持

pBI221-EGFP

收藏
  • ¥800
  • LSM Bio
  • 进口
  • PVT3007
  • 2025年07月15日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      负20摄氏度

    • 保质期

      3个月

    • 英文名

      pBI221-EGFP

    • 库存

      100

    • 供应商

      LSMBIO

    • 规格

      2ug

    pBI221-EGFP

    Search name

    pBI221-EGFP,Plasmid pBI221-EGFP,pBI221-EGFP vector

     

    pBI221-EGFP Information

    Promoter: CaMV 35S, Lac

    Replicon: ori

    Terminator: NOS

    Plasmid classification: plant series, protein overexpression vector

    Plasmid size: 4530bp

    Prokaryotic resistance: Amp

    Cloned strain: DH5 alpha

    Culture conditions: 37 centigrade, aerobic LB

    5'sequencing primers: 35S:GACGCACAATCCCACTATCC

    3'sequencing primers: primers designed according to sequence

    Expression: Plant
    Use: Plant expression

     

    pBI221-EGFP Description

    Most studies related to determining the expression profile of genes and specific promoters used histochemical localization of the reporter gene, gusA. While the histochemical method for visualizing gusA expression suffers from several limitations in the determination of gene expression and location, especially in the tissues with high background acitivty. To solve this problem, a transient expession vector pBI221-RFP/GFP, was constructed using GFP and RFP as double fluorescent marker genes. This vector used CaMV 35S promoter to drive GFP and determine the transforming efficiency. It analyzed expression profile of the target gene and promoter through the RFP activities of the tranformed tissues. Through the specific promoter AGPL1 from watermelon and E8 promoter from tomato, it is resistible to use this vector to study the expression patterns of promoters. Results indicated that the pBI221-RFP/GFP is a very efficient transient expression vector that can be verify the functions of the genes and promoters.

     

    pBI221-EGFP Sequence

    LOCUS       Exported                4530 bp ds-DNA     circular SYN 13-SEP-2016
    DEFINITION  synthetic circular DNA
    ACCESSION   .
    VERSION     .
    KEYWORDS    Untitled 2
    SOURCE      synthetic DNA construct
      ORGANISM  synthetic DNA construct
    REFERENCE   1  (bases 1 to 4530)
      AUTHORS   .
      TITLE     Direct Submission
      JOURNAL   Exported Tuesday, September 13, 2016 from SnapGene Viewer 3.2.1
               
    FEATURES             Location/Qualifiers
         source          1..4530
                         /organism="synthetic DNA construct"
                         /mol_type="other DNA"
         promoter        512..857
                         /note="CaMV 35S promoter"
                         /note="strong constitutive promoter from cauliflower mosaic
                         virus"
         CDS             903..1622
                         /codon_start=1
                         /product="enhanced GFP"
                         /note="EGFP"
                         /note="mammalian codon-optimized"
                         /translation="MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTL
                         KFICTTGKLPVPWPTLVTTFTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDD
                         GNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIK
                         VNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLL
                         EFVTAAGITHGMDELYK"
         terminator      1641..1893
                         /note="NOS terminator"
                         /note="nopaline synthase terminator and poly(A) signal"
         primer_bind     complement(1902..1918)
                         /note="M13 fwd"
                         /note="common sequencing primer, one of multiple similar 
                         variants"
         promoter        2392..2496
                         /gene="bla"
                         /note="AmpR promoter"
         CDS             2497..3357
                         /codon_start=1
                         /gene="bla"
                         /product="beta-lactamase"
                         /note="AmpR"
                         /note="confers resistance to ampicillin, carbenicillin, and
                         related antibiotics"
                         /translation="MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYI
                         ELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYS
                         PVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRW
                         EPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSA
                         LPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGAS
                         LIKHW"
         rep_origin      3528..4116
                         /direction=RIGHT
                         /note="ori"
                         /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of 
                         replication"
         protein_bind    4404..4425
                         /bound_moiety="E. coli catabolite activator protein"
                         /note="CAP binding site"
                         /note="CAP binding activates transcription in the presence 
                         of cAMP."
         promoter        4440..4470
                         /note="lac promoter"
                         /note="promoter for the E. coli lac operon"
         protein_bind    4478..4494
                         /bound_moiety="lac repressor encoded by lacI"
                         /note="lac operator"
                         /note="The lac repressor binds to the lac operator to 
                         inhibit transcription in E. coli. This inhibition can be 
                         relieved by adding lactose or 
                         isopropyl-beta-D-thiogalactopyranoside (IPTG)."
         primer_bind     4502..4518
                         /note="M13 rev"
                         /note="common sequencing primer, one of multiple similar 
                         variants"
    ORIGIN
            1 aagcttgcat gcctgcaggt ccccagatta gccttttcaa tttcagaaag aatgctaacc
           61 cacagatggt tagagaggct tacgcagcag gtctcatcaa gacgatctac ccgagcaata
          121 atctccagga aatcaaatac cttcccaaga aggttaaaga tgcagtcaaa agattcagga
          181 ctaactgcat caagaacaca gagaaagata tatttctcaa gatcagaagt actattccag
          241 tatggacgat tcaaggcttg cttcacaaac caaggcaagt aatagagatt ggagtctcta
          301 aaaaggtagt tcccactgaa tcaaaggcca tggagtcaaa gattcaaata gaggacctaa
          361 cagaactcgc cgtaaagact ggcgaacagt tcatacagag tctcttacga ctcaatgaca
          421 agaagaaaat cttcgtcaac atggtggagc acgacacact tgtctactcc aaaaatatca
          481 aagatacagt ctcagaagac caaagggcaa ttgagacttt tcaacaaagg gtaatatccg
          541 gaaacctcct cggattccat tgcccagcta tctgtcactt tattgtgaag atagtggaaa
          601 aggaaggtgg ctcctacaaa tgccatcatt gcgataaagg aaaggccatc gttgaagatg
          661 cctctgccga cagtggtccc aaagatggac ccccacccac gaggagcatc gtggaaaaag
          721 aagacgttcc aaccacgtct tcaaagcaag tggattgatg tgatatctcc actgacgtaa
          781 gggatgacgc acaatcccac tatccttcgc aagacccttc ctctatataa ggaagttcat
          841 ttcatttgga gagaacacgg gggactctag aggatccgaa ttcgagctcc gtcgacaagc
          901 ttatggtgag caagggcgag gagctgttca ccggggtggt gcccatcctg gtcgagctgg
          961 acggcgacgt aaacggccac aagttcagcg tgtccggcga gggcgagggc gatgccacct
         1021 acggcaagct gaccctgaag ttcatctgca ccaccggcaa gctgcccgtg ccctggccca
         1081 ccctcgtgac caccttcacc tacggcgtgc agtgcttcag ccgctacccc gaccacatga
         1141 agcagcacga cttcttcaag tccgccatgc ccgaaggcta cgtccaggag cgcaccatct
         1201 tcttcaagga cgacggcaac tacaagaccc gcgccgaggt gaagttcgag ggcgacaccc
         1261 tggtgaaccg catcgagctg aagggcatcg acttcaagga ggacggcaac atcctggggc
         1321 acaagctgga gtacaactac aacagccaca acgtctatat catggccgac aagcagaaga
         1381 acggcatcaa ggtgaacttc aagatccgcc acaacatcga ggacggcagc gtgcagctcg
         1441 ccgaccacta ccagcagaac acccccatcg gcgacggccc cgtgctgctg cccgacaacc

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Upregulation of Antioxidant Capacity and Nucleotide Precursor Availability Suffices for Oncogenic Transformation Author:YangZhang1YiXu1WenyunLu23Jonathan M.Ghergurovich24LiliGuo56Ian A.Blair5Joshua D.Rabinowitz23XiaoluYang17 Received 22 January 2020, Revised 4 August 2020, Accepted 30 September 2020, Available online 6 November 2020. Published: November 6, 2020 Cell Metabolism Available online 6 November 2020 In Press doi: doi.org/10.1016/j.cmet.2020.10.002
    相关实验
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1
    上海联迈生物工程有限公司
    2025年11月20日询价
    ¥1200
    上海晶风生物科技有限公司
    2025年03月26日询价
    ¥680
    温州科淼生物科技有限公司
    2025年07月12日询价
    ¥800
    上海钰博生物科技有限公司
    2025年07月09日询价
    ¥800
    武汉维克赛思科技有限公司
    2025年07月16日询价
    文献支持
    pBI221-EGFP
    ¥800